M.E.A. Spaanderman

Kempener, B. M. J. G., Jorissen, L. M., Mulder, E. G., Ghossein-Doha, C., van Drongelen, J., Scholten, R. R., Lees, C. C., de Haas, S., Janssen, E. B. N. J., & Spaanderman, M. E. A. (2026). Hemodynamic changes in pregnancies with impaired fetal growth: A systematic review and meta-analysis. Acta Obstetricia et Gynecologica Scandinavica, 105(2), 215-224. https://doi.org/10.1111/aogs.70102

van Doorn, D. P. C., Al-Nasiry, S., Spaanderman, M. E. A., Damoiseaux, J. G. M. C., van Paassen, P., & Timmermans, S. A. M. E. G. (2026). Thrombotic Microangiopathy During Pregnancy: Role of Soluble Fms-like Tyrosine Kinase-1-Placental Growth Factor Ratios. American Journal of Kidney Diseases, 87(2), 278-283. https://doi.org/10.1053/j.ajkd.2025.09.017

Jansen, G., De Rooy, A., Janssen, E., Altintas, S., van 't Hof, A., Mihl, C., Kietselaer, B., Spaanderman, M., & Ghossein-Doha, C. (2026). Atherosclerosis after pre-eclampsia: systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology, 67(1), 15-26. https://doi.org/10.1002/uog.70014

Hulshoff, C. C., Spaanderman, M. E. A., Scholten, R. R., & Van Drongelen, J. (2026). Predictive factors for emergency cervical cerclage efficacy in singleton and twin pregnancies: A retrospective cohort study. Acta Obstetricia et Gynecologica Scandinavica, 105(1), 105-116. https://doi.org/10.1111/aogs.70076

van der Windt, L. I., Meliezer, J. A. L., Pajkrt, E., Spaanderman, M. E. A., Scheepers, H. C. J., Mol, B. W., Oudijk, M. A., Ravelli, A. C. J., & Roos, C. (2026). School Performance After Maintenance Tocolysis With Nifedipine for Threatened Preterm Birth: 12-Year Follow-Up of the APOSTEL 2 Trial. Bjog-an International Journal of Obstetrics and Gynaecology, 133(2), 334-344. https://doi.org/10.1111/1471-0528.70030

Hamers, M., Janssen, E. B. N. J., Bottema, I., Villamor, E., Van Mechelen, K., & Spaanderman, M. E. A. (2025). Reference ranges of blood glucose values in healthy term neonates in their first days of life: a systematic review and meta-analysis. European Journal of Pediatrics, 185(1), Article 19. https://doi.org/10.1007/s00431-025-06618-3

Moes, S. L., Depmann, M., Kvamme, I., Schuit, E., Anker, E. I. ., Dirken, J., Van Eerden, L., Franx, A., Gordijn, S., De Heus, R., Koenen, S., Van Der Made, F., Santegoets, L., Spaanderman, M., Lely, A. T., & Bekker, M. N. (2025). Safety and impact of self-monitoring blood pressure through a digital platform in high-risk pregnancies in 11 hospitals: The multicenter before-after SAFE@home II study. Pregnancy Hypertension, 42, Article 101268. https://doi.org/10.1016/j.preghy.2025.101268

Orabona, R., Sciatti, E., Prefumo, F., Spaanderman, M. E. A., Senni, M., de Boer, R. A., & Ghossein-Doha, C. (2025). Sodium-Glucose Cotransporter 2 Inhibitors After Preeclampsia: A Therapeutic Promise? JACC: Heart Failure, 13(11), Article 102688. https://doi.org/10.1016/j.jchf.2025.102688

Stampalija, T., Lees, C., Ghi, T., Cornette, J., Gyselaers, W., Ferrazzi, E., Mousa, T., Spaanderman, M., Thilaganathan, B., Valensise, H., & Collaborators (2025). ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction. Ultrasound in Obstetrics & Gynecology, 66(5), 681-696. https://doi.org/10.1002/uog.70040

Moes, S. L., Depmann, M., Ingelin, K., In 't Anker, E., Dirken, J., Van Eerden, L., Franx, A., De Heus, R., Gordijn, S. J., Koenen, S., Lahr, M. M. H., Lely, T. A., van der Made, F., Santegoets, L., Spaanderman, M., Schuit, E., & Bekker, M. N. (2025). Implementing the SAFE@home digital platform for blood pressure home monitoring for patients with (a risk of) hypertensive disorders of pregnancy: A barrier and facilitator analysis among obstetric healthcare professionals. Digital health, 11. https://doi.org/10.1177/20552076251376518